Significant Revenue Growth
Cronos Group achieved a 35% year-over-year increase in annual net revenue, highlighting strong performance across Canada, Israel, and international markets.
Improved Margins
The company nearly doubled its adjusted gross margins and reported a 12 percentage point improvement in adjusted gross margin for the full year 2024.
Market Leadership in Canada
Spinach brand became the number one cannabis brand in Canada by market share, with top rankings in edibles, flower, and vapes.
Strong Financial Position
Cronos maintains a strong balance sheet with $859 million in cash and cash equivalents, providing a solid foundation for future growth and expansion.
Positive Adjusted EBITDA Trend
Adjusted EBITDA improved by 45% year-over-year, indicating better operational efficiency and cost management.
Successful Expansion in International Markets
Cronos Group made progress in Germany and the UK, showing promising growth and potential for expansion.
R&D Advancements
Significant advancements in cannabis genetics and breeding programs, leading to new strains and improved cannabinoid yield.